Transgene Biotek Key Metrics

BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs

6.52 +0.03 (0.46%)Updated : 26 Nov 2024

Ratios

Return on average equity - 5 year average	-34.70
Net Income/employee - trailing 12 month	-
Revenue/employee - most recent fiscal year	-
Return on investment - most recent fiscal year	-0.50
Return on average assets - most recent fiscal year	-0.46
Receivables turnover - most recent fiscal year	27.96
Return on investment - trailing 12 month	-0.20
Return on average assets - trailing 12 month	-0.18
Inventory turnover - most recent fiscal year	0.02
Inventory turnover - trailing 12 month	0.01
Revenue/employee - trailing 12 month	-
Return on average assets - 5 year average	-4.98
Net Income/employee - most recent fiscal year	-
Return on average equity - trailing 12 month	-2.35
Receivables turnover - trailing 12 month	0.00
Asset turnover - most recent fiscal year	0.00
Asset turnover - trailing 12 month	0.00
Return on average equity - most recent fiscal year	-5.94
Return on investment - 5 year average	-5.39